Evidence map›Paper›PMID 38139203›Full record

ArticleInternational journal of molecular sciences2023

Hybrid Nanoparticle-Assisted Chemo-Photothermal Therapy and Photoacoustic Imaging in a Three-Dimensional Breast Cancer Cell Model.

Barbara Carrese, Chiara Cavallini, Paolo Armanetti, Brigida Silvestri, Gaetano Calì, Giuseppina Luciani, Gennaro Sanità, Luca Menichetti, Annalisa Lamberti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Barbara CarreseDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-5867-4775
Chiara CavalliniInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0002-3456-5152
Paolo ArmanettiInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.ORCID 0000-0002-8516-536X
Brigida SilvestriDepartment of Civil, Construction and Environmental Engineering, University of Naples Federico II, 80125 Naples, Italy.ORCID 0000-0003-1654-8698
Gaetano CalìInstitute of Endocrinology and Molecular Oncology, National Research Council, 80131 Naples, Italy.
Giuseppina LucianiDepartment of Chemical, Materials and Production Engineering, University of Naples Federico II, 80125 Naples, Italy.ORCID 0000-0002-1169-0137
Gennaro SanitàInstitute of Applied Sciences and Intelligent Systems-Unit of Naples, National Research Council, 80131 Naples, Italy.ORCID 0000-0002-8943-6980
Luca MenichettiInstitute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.
Annalisa LambertiDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-5498-2930
University of Naples Federico II · ITIstituto di Fisiologia Clinica · ITInstitute for Experimental Endocrinology and Oncology · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioinspired nanoparticles have recently been gaining attention as promising multifunctional nanoplatforms for therapeutic applications in cancer, including breast cancer. Here, the efficiency of the chemo-photothermal and photoacoustic properties of hybrid albumin-modified nanoparticles (HSA-NPs) loaded with doxorubicin was evaluated in a three-dimensional breast cancer cell model. The HSA-NPs showed a higher uptake and deeper penetration into breast cancer spheroids than healthy breast cell 3D cultures. Confocal microscopy revealed that, in tumour spheroids incubated with doxorubicin-loaded NPs for 16 h, doxorubicin was mainly localised in the cytoplasm, while a strong signal was detectable at the nuclear level after 24 h, suggesting a time-dependent uptake. To evaluate the cytotoxicity of doxorubicin-loaded NPs, tumour spheroids were treated for up to 96 h with increasing concentrations of NPs, showing marked toxicity only at the highest concentration of doxorubicin. When doxorubicin administration was combined with laser photothermal irradiation, enhanced cytotoxicity was observed at lower concentrations and incubation times. Finally, the photoacoustic properties of doxorubicin-loaded NPs were evaluated in tumour spheroids, showing a detectable signal increasing with NP concentration. Overall, our data show that the combined effect of chemo-photothermal therapy results in a shorter exposure time to doxorubicin and a lower drug dose. Furthermore, owing to the photoacoustic properties of the NPs, this nanoplatform may represent a good candidate for theranostic applications.

Indexed as

Breast NeoplasmsHyperthermia, InducedNanoparticlesPhotoacoustic TechniquesCell Line, TumorDoxorubicinFemaleHumansPhototherapyPhotothermal TherapyDoxorubicinalbumin-modified nanoparticlesbreast cancer spheroidsdoxorubicinmelaninphotoacoustic imagingphotothermal therapy

Identifiers

PMID38139203
PMCPMC10743567
OpenAlexW4389623730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.